| DB ID | MyCo_6057 |
| Title | Decoding serological response to Candida cell wall immunome into novel diagnostic, prognostic, and therapeutic candidates for systemic candidiasis by proteomic and bioinformatic analyses |
| Year | 2005 |
| PMID | 16195222 |
| Fungal Diseases involved | Systemic candidiasis |
| Associated Medical Condition | None |
| Genus | Candida |
| Species | albicans |
| Organism | Candida albicans |
| Ethical Statement | None |
| Site of Infection | None |
| Opportunistic invasive | None |
| Sample type | Body fluid |
| Sample source | Serum |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | anti-Bgl2p |
| Biomarker Full Name | anti-1,3-β-glucosidase |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | Spain |
| Cohort | Between December 1997 and March 2003, serum specimens from 48 patients with lab- oratory-confirmed SC belonging to different risk groups were ob- tained on the day of culture sampling at the Salamanca University Hospital (Spain) after informed consent was given. To provide data on assay specificity, serum samples from 118 individuals without clinical or microbiologi- cal evidence of SC and with a similar age and sex distribution to cases were evaluated as controls. |
| Cohort No. | 48 Patients and 118 control |
| Age Group | None |
| P Value | None |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | Bioinformatics analysis |
| Analysis Method | Proteomic based Bioinformatic Analyses |
| ELISA kits | None |
| Assay Data | None |
| Validation Techniques used | Proteomic based Bioinformatic Analyses |
| Up Regulation Down Regulation | Positive |
| Sequence Data | None |
| External Link | None |
